Lab leasing is showing small signs of improvement in select markets across the U.S., offering a glimmer of hope for landlords stuck in a supply glut for more than two years. But underneath the leasing ...

Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...